TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32403906

Group type: EXPERIMENTAL
Intervention: Acidif plus® (two tablets per day for 7 days)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Fosfomycin (two consecutive days)
Number of subjects: 88
Study: 35040415

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg OD or 200 mg BID
Number of subjects: 99

Group type: COMPARATOR
Intervention: Pioglitazone (Control)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ) and Pioglitazone (Control)
Number of subjects: 99
Study: 33551284

Group type: EXPERIMENTAL
Intervention: Active 20 Hz rTMS applied to the bilateral DLPFC
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 83
Study: 32539079

Group type: EXPERIMENTAL
Intervention: Hookworm treatment (25 Necator americanus larvae transcutaneously)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Hookworm treatment
Number of subjects: 71
Study: 33660875

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg daily for 4 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 14
Study: 32534626

Group type: EXPERIMENTAL
Intervention: Anti-SARS-CoV-2 IgG antibodies testing
Number of subjects: 2766
Study: 34747568

Group type: EXPERIMENTAL
Intervention: simplified team-based learning (sTBL)
Number of subjects: 179

Group type: COMPARATOR
Intervention: interactive lectures (IL)
Number of subjects: 179
Study: 34076308

Group type: EXPERIMENTAL
Intervention: Calcitriol (1 μg for 1 week before surgery)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 32590010

Group type: EXPERIMENTAL
Intervention: Alcoholic Bétadine™ 5% with iodine-impregnated 3M™ Ioban2™
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alcoholic chlorhexidine 0.5%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mechanical cleansing and sterile draping
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Preoperative shower
Number of subjects: 30
Study: 35021257

Group type: EXPERIMENTAL
Intervention: Patient-Reported Villalta Scale version 2 (PRV2)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Original Villalta scale
Number of subjects: 181
Study: 33751644

Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection (FMD) with splinting of teeth 33–43
Number of subjects: 34

Group type: COMPARATOR
Intervention: Full-mouth disinfection (FMD) without splinting (control group)
Number of subjects: 34
Study: 32367730

Group type: EXPERIMENTAL
Intervention: Genetically predicted alcohol consumption
Number of subjects: 94
Study: 35113137

Group type: EXPERIMENTAL
Intervention: Intravitreal pegcetacoplan monthly (15 mg)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Intravitreal pegcetacoplan every other month (15 mg)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 167
Study: 33498220

Group type: EXPERIMENTAL
Intervention: High NO3‐, low NO2‐ (HL; 572 mg NO3‐, 32 mg NO2‐)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Medium NO3‐, medium NO2‐ (MM; 280 mg NO3‐, 237 mg NO2‐)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low NO3‐, medium NO2‐ (LM; 43 mg NO3‐, 262 mg NO2‐)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL; low NO3‐, low NO2‐: 8 mg NO3‐, 5.8 mg NO2‐)
Number of subjects: 11
Study: 33630620

Group type: EXPERIMENTAL
Intervention: Warning message during personality test
Number of subjects: 1447

Group type: COMPARATOR
Intervention: Control message during personality test
Number of subjects: 1447
Study: 34962245

Group type: EXPERIMENTAL
Intervention: Aquatic group (AG)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Land-based group (LG)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Home group (HG)
Number of subjects: 57
Study: 36323122

Group type: EXPERIMENTAL
Intervention: Nudges (students set a goal regarding their effort in not throwing away plastic products)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boosts (students wrote an essay to increase empathy for parties impacted by environmental issues)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both nudges and boosts
Number of subjects: 0

Group type: COMPARATOR
Intervention: None (neither nudges nor boosts)
Number of subjects: 0
Study: 32700186

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention delivered to daycare providers and parents
Number of subjects: 215

Group type: COMPARATOR
Intervention: Standard daycare curriculum (COM)
Number of subjects: 215
Study: 32747931

Group type: EXPERIMENTAL
Intervention: Oral surotomycin (250 mg twice daily)
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Oral vancomycin (125 mg four times per day)
Number of subjects: 1147
Study: 36450593

Group type: EXPERIMENTAL
Intervention: Surgery group (SG)
Number of subjects: 7297

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 7297

Group type: EXPERIMENTAL
Intervention: Validation group
Number of subjects: 7297
Study: 33734043

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no anti-inflammatory therapy)
Number of subjects: 22
Study: 33926433

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (VA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 36
Study: 32201165

Group type: EXPERIMENTAL
Intervention: BPSS app
Number of subjects: 102

Group type: COMPARATOR
Intervention: No-BPSS app
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study: 35354247

Group type: EXPERIMENTAL
Intervention: DARA SC
Number of subjects: 522

Group type: COMPARATOR
Intervention: DARA IV
Number of subjects: 522
Study: 34538546

Group type: COMPARATOR
Intervention: 1 dose of 8-mg intravenous dexamethasone (1D-group)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 2 doses of 8-mg intravenous dexamethasone (2D-group)
Number of subjects: 115
Study: 32958699

Group type: EXPERIMENTAL
Intervention: FOLFOX or FOLFIRI combined with cetuximab
Number of subjects: 613

Group type: COMPARATOR
Intervention: FOLFOX or FOLFIRI combined with bevacizumab
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: rs11649255 in AXIN1
Number of subjects: 613
Study: 32105355

Group type: EXPERIMENTAL
Intervention: D‐PRESCRIBE (NSAIDs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 36183982

Group type: EXPERIMENTAL
Intervention: 0.5% M. oleifera leaf extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% or 0.75% M. oleifera leaf extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.35%‐0.48% M. oleifera leaf extract
Number of subjects: 0
Study: 34648568

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (IVR) intervention for three sessions: 4 hours before chemotherapy, 5 minutes before and during the first course chemotherapy, and 5 minutes before and during the second course chemotherapy.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care only (Control group).
Number of subjects: 20
Study: 32536538

Group type: EXPERIMENTAL
Intervention: Liposomal lidocaine-prilocaine formulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-liposomal lidocaine-prilocaine formulation
Number of subjects: 40
Study: 35698000

Group type: EXPERIMENTAL
Intervention: Secukinumab low dose (LD) 75/75/150 mg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Secukinumab high dose (HD) 75/150/300 mg
Number of subjects: 84
Study: 34027851

Group type: EXPERIMENTAL
Intervention: TeleNP
Number of subjects: 150

Group type: COMPARATOR
Intervention: F‐F
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: TeleNP and F‐F
Number of subjects: 150
Study: 33713826

Group type: EXPERIMENTAL
Intervention: Post-discharge low-molecular-weight heparin (LMWH) injections once-daily for 30 days
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo injections once-daily for 30 days
Number of subjects: 133
Study: 34787919

Group type: EXPERIMENTAL
Intervention: TMFI treatment (Tixel®, Novoxel®, Israel)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: NAFL treatment (non‐ablative fractional 1565 nm laser, ResurFX®, Lumenis, Israel)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both TMFI and NAFL treatments
Number of subjects: 68
Study: 32173636

Group type: EXPERIMENTAL
Intervention: Nicergoline combined with oxiracetam
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nicergoline alone
Number of subjects: 120
Study: 33156242

Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (BCAA) concentrations at 48 hours
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (BCAA) concentrations
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Valine, leucine, and isoleucine (BCAAs)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Vasopressor free days
Number of subjects: 228
Study: 32167712

Group type: EXPERIMENTAL
Intervention: Modified Wallace anastomotic technique
Number of subjects: 140

Group type: COMPARATOR
Intervention: Traditional ileal conduit
Number of subjects: 140
Study: 34182157

Group type: EXPERIMENTAL
Intervention: CARES smartphone app
Number of subjects: 250

Group type: COMPARATOR
Intervention: Existing online alcohol education (AE) program
Number of subjects: 250
Study: 32904579

Group type: EXPERIMENTAL
Intervention: Self-Selected Training Intensity (SSTI) performed three times per week, 30-50 minutes per session (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group participated in health education meetings once per week (n=20)
Number of subjects: 40
Study: 35938330

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (routine protocol)
Number of subjects: 68
Study: 33909662

Group type: EXPERIMENTAL
Intervention: Focused ultrasound cavitation and moderate aerobic exercise for three months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Moderate aerobic exercise only
Number of subjects: 34
Study: 32799029

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBTI)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Sleep restriction therapy (SRT)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sleep education control
Number of subjects: 113
Study: 35413873

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (SDF) treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard package of glass ionomer sealants and atraumatic restorative treatment (ART)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Comparison of SDF and standard treatment
Number of subjects: 160
Study: 33135283

Group type: EXPERIMENTAL
Intervention: Comic
Number of subjects: 151

Group type: COMPARATOR
Intervention: Video
Number of subjects: 151

Group type: COMPARATOR
Intervention: Brochure
Number of subjects: 151
Study: 32398581

Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Leg wrapping
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control (sham leg wrapping and saline infusion)
Number of subjects: 144
Study: 36160639

Group type: EXPERIMENTAL
Intervention: Varenicline + Lorcaserin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Varenicline + Placebo
Number of subjects: 84
Study: 34553463

Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract (300 mg twice daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34058041

Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal left primary motor cortex stimulation, 2 mA, 20 min, 36 patients)
Number of subjects: 77
Study: 32051393

Group type: EXPERIMENTAL
Intervention: Gankyrin knockdown
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: CCR3 inhibitor SB328437
Number of subjects: 256

Group type: COMPARATOR
Intervention: Gankyrin overexpression
Number of subjects: 256

Group type: COMPARATOR
Intervention: Gankyrin and STAT3 or CCL24 expression
Number of subjects: 256
Study: 35310186

Group type: EXPERIMENTAL
Intervention: Crizotinib combined with chemotherapy (EG)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Chemotherapy alone (CG)
Number of subjects: 90
Study: 33793050

Group type: EXPERIMENTAL
Intervention: 300 mg vitamin C from drink
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 300 mg vitamin C from kiwifruit
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 10
Study: 32609534

Group type: EXPERIMENTAL
Intervention: Goreisan (2.5 g orally on the night before surgery and on the morning of surgery)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no Goreisan)
Number of subjects: 50
Study: 36029876

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 1864

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 1864

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1864

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1864

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1864

Group type: EXPERIMENTAL
Intervention: Trials 1 and 2 (combined)
Number of subjects: 1864
Study: 32607598

Group type: EXPERIMENTAL
Intervention: 50 mg riluzole
Number of subjects: 52

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 52
Study: 36014824

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 345
Study: 33145897

Group type: EXPERIMENTAL
Intervention: RCTs evaluating outcomes relevant to children's oral health; specific interventions not available.
Number of subjects: 0
Study: 34801112

Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (1.8 x 10^6 PfSPZ)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 176
Study: 33638976

Group type: EXPERIMENTAL
Intervention: Empiric TB therapy
Number of subjects: 850

Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 850
Study: 34510395

Group type: EXPERIMENTAL
Intervention: Oral supplementation with sucrosomial magnesium associated with therapeutic exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapeutic exercise only
Number of subjects: 0
Study: 32221582

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744
Study: 35670271

Group type: EXPERIMENTAL
Intervention: Visual inspection (VIS)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Visual + radiographic (RAD) assessment
Number of subjects: 205
Study: 33512679

Group type: EXPERIMENTAL
Intervention: Therapeutic cancer vaccines, specific details not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination partners (e.g., checkpoint inhibitors), specific details not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized, phase 3 studies of therapeutic cancer vaccines, specific details not available.
Number of subjects: 0
Study: 33238244

Group type: EXPERIMENTAL
Intervention: Graston Technique® (GT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Instrument-Assisted Soft Tissue Mobilization (IASTM)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 23
Study: 34197511

Group type: EXPERIMENTAL
Intervention: Acknowledging the link between climate change and agricultural production in outreach mailings
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Invitation to a webinar about conservation practices
Number of subjects: 10000
Study: 32727619

Group type: EXPERIMENTAL
Intervention: Sanfu herbal patch (SHP)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 35646177

Group type: EXPERIMENTAL
Intervention: Sticky Bone (SB) technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bone Shell (BS) technique
Number of subjects: 80
Study: 34652627

Group type: EXPERIMENTAL
Intervention: 10% (20AA) compound AA injection
Number of subjects: 75

Group type: COMPARATOR
Intervention: 8.5% (18AA‐II) compound AA injection
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition support therapy with iso‐nitrogen and iso‐calorie
Number of subjects: 75
Study: 36299407

Group type: EXPERIMENTAL
Intervention: Brief face‐to‐face intervention delivered by a trained physician plus information leaflet (Intervention Group, IG)
Number of subjects: 1148

Group type: COMPARATOR
Intervention: Simple feedback including a leaflet (Control Group, CG)
Number of subjects: 1148
Study: 33706795

Group type: EXPERIMENTAL
Intervention: Noble metal alloy (NMA) coated BIP Foley Catheter
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Non-coated control catheter
Number of subjects: 1000
Study: 32143986

Group type: EXPERIMENTAL
Intervention: Multimedia counseling using the drawMD OB/GYN iPad™ application
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Multimedia counseling
Number of subjects: 72
Study: 35341360

Group type: EXPERIMENTAL
Intervention: VR-based mirror therapy (VR-MT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional occupational therapy (COT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Mirror therapy (MT)
Number of subjects: 54
Study: 33050728

Group type: EXPERIMENTAL
Intervention: Automated insulin delivery
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy
Number of subjects: 36
Study: 34346295

Group type: COMPARATOR
Intervention: Chitosan at 0 mg/kg concentrate
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chitosan at 400 mg/kg concentrate
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chitosan at 800 mg/kg concentrate
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chitosan at 1200 mg/kg concentrate
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chitosan at 1600 mg/kg concentrate
Number of subjects: 5
Study: 32921614

Group type: EXPERIMENTAL
Intervention: HCA (Hypothermic Circulatory Arrest)
Number of subjects: 696

Group type: COMPARATOR
Intervention: No HCA
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 696
Study: 616852791

Group type: EXPERIMENTAL
Intervention: Group A: tube voltage 100 kV; contrast agent iohexol (350 mg I/ml), reconstructed by filtered back projection
Number of subjects: 59

Group type: COMPARATOR
Intervention: Group B: tube voltage 80 kV; contrast agent iodixanol (270 mg I/ml), reconstructed by algebraic reconstruction technique
Number of subjects: 59
Study: 35802065

Group type: EXPERIMENTAL
Intervention: Prehabilitation intervention based on the modified fear-avoidance model
Number of subjects: 118
Study: 33896034

Group type: EXPERIMENTAL
Intervention: Experienced surgeons (≥ 25 mitral valve operations/year)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Less experienced surgeons
Number of subjects: 575
Study: 32243576

Group type: EXPERIMENTAL
Intervention: O-R brush (Oral-B iO)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sonic brush
Number of subjects: 90
Study: 34282644

Group type: EXPERIMENTAL
Intervention: 3-month micro-video health education program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (micro-video health education and routine care)
Number of subjects: 80
Study: 33711986

Group type: EXPERIMENTAL
Intervention: Pastille containing four polysaccharides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control product (Parafilm®)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pastille
Number of subjects: 0
Study: 32069356

Group type: EXPERIMENTAL
Intervention: Whey protein (n=137)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Casein (n=393)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Milk protein (n=72)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Greater protein doses
Number of subjects: 602

Group type: COMPARATOR
Intervention: Older individuals (aged 71 ± 5 y)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Young individuals (aged 22 ± 3 y)
Number of subjects: 602
Study: 35034345

Group type: EXPERIMENTAL
Intervention: Vitamin D3 25000 I.U. ODF under fed conditions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Vitamin D3 25000 I.U. oral solution under fed conditions
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vitamin D3 25000 I.U. ODF under fasting conditions
Number of subjects: 48
Study: 33522946

Group type: EXPERIMENTAL
Intervention: Single oral dose of 500,000 IU cholecalciferol (5 capsules of 100,000 IU)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1264
Study: 33754523

Group type: EXPERIMENTAL
Intervention: Underlay myringoplasty
Number of subjects: 80

Group type: COMPARATOR
Intervention: Overlay myringoplasty
Number of subjects: 80
Study: 616836595

Group type: EXPERIMENTAL
Intervention: Anhydrous caffeine (5 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL-drink only)
Number of subjects: 24
Study: 35165382

Group type: EXPERIMENTAL
Intervention: Average protein (15%) intake
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Higher regional DNAm at TXNIP
Number of subjects: 639
Study: 33978286

Group type: EXPERIMENTAL
Intervention: Zanarini Rating Scale for Borderline Personality Disorder (ZAN‐BPD)
Number of subjects: 276
Study: 32720908

Group type: EXPERIMENTAL
Intervention: Do CHANGE 2 intervention
Number of subjects: 0
Study: 35799756

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Sulfate (200 mg orally 8 hourlies thrice a day for 5 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg orally twice a day for 5 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg orally daily on day 1, followed by 250 mg orally twice a day on days 2‐5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Hydroxychloroquine, Oseltamivir, and Azithromycin
Number of subjects: 0
Study: 32151803

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) at 10 mg/kg/day up-titrated to 20-30 mg/kg/day for 12 weeks
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 30 mg/kg/day
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 263
Study: 35690256

Group type: EXPERIMENTAL
Intervention: Homotopic conditioning (electrical stimulation of the right index finger)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heterotopic conditioning (electrical stimulation of the right little finger)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unconditioned TMS (single‐pulse TMS of the left M1‐HAND)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Randomly intermixed stimulation conditions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Blocked stimulation (single condition repeated five or ten times)
Number of subjects: 20